Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thrombosis and anticoagulation.

J Hirsh1, J I Weitz

  • 1Hamilton Civic Hospitals Research Centre, Ontario, Canada.

Seminars in Hematology
|December 14, 1999
PubMed
Summary
This summary is machine-generated.

Recent advances in thrombosis research have yielded novel antithrombotic agents targeting blood coagulation and platelet activation. Future therapies may focus on modulating vessel wall function to prevent and treat thrombosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of 5-mg and 10-mg loading doses in initiation of warfarin therapy.

Annals of internal medicine·1997
Same author

Effect of nonspecific binding to plasma proteins on the antithrombin activities of unfractionated heparin, low-molecular-weight heparin, and dermatan sulfate.

Circulation·1997
Same author

Fish oils and low-molecular-weight heparin for the reduction of restenosis after percutaneous transluminal coronary angioplasty. The EMPAR Study.

Circulation·1996
Same author

Comparison of the relative efficacy and safety of low molecular weight heparin and unfractionated heparin for the treatment of venous thrombosis.

Haemostasis·1996
Same author

Histomorphometric analysis of the effects of standard heparin on trabecular bone in vivo.

Blood·1996
Same author

The relation between the activated partial thromboplastin time response and recurrence in patients with venous thrombosis treated with continuous intravenous heparin.

Archives of internal medicine·1996
Same journal

Pain in SCD-Many mechanisms and mysteries.

Seminars in hematology·2026
Same journal

The many facets of cardiopulmonary complications in sickle cell disease.

Seminars in hematology·2026
Same journal

Clonal hematopoiesis in the setting of sickle cell disease and its relevance to curative therapies.

Seminars in hematology·2026
Same journal

Treatment of myeloproliferative neoplasms: Exploring new horizons of who and when to cytoreduce in patients with polycythemia vera and essential thrombocytosis.

Seminars in hematology·2026
Same journal

Telomeres biology disorders: the past, the present and the future.

Seminars in hematology·2026
Same journal

Cardiovascular complications in patients with myeloproliferative neoplasms: What hematologists need to know.

Seminars in hematology·2026
See all related articles

Area of Science:

  • Biomedical Sciences
  • Clinical Trials Methodology
  • Thrombosis Research

Background:

  • Thrombosis research has significantly advanced over the past 50 years.
  • Progress is driven by improvements in biomedical sciences and clinical trials.
  • Understanding thrombogenesis mechanisms is key.

Observation:

  • New antithrombotic agents targeting coagulation and platelet activation have been discovered.
  • Low-molecular-weight heparins (LMWH), glycoprotein (GP) IIb/IIIa antagonists, and adenosine diphosphate (ADP) receptor inhibitors are clinically used.
  • The vessel wall plays a dual role in promoting and protecting against thrombosis.

Findings:

  • Numerous antithrombotic compounds are in development.
  • Established therapies include LMWH, GP IIb/IIIa antagonists, and ADP receptor inhibitors.

Related Experiment Videos

  • Emerging therapies aim to modulate vessel wall function.

    • Implications:

    • These developments offer improved prevention and treatment strategies for thrombosis.
    • Future research focuses on vessel wall-targeted therapies.
    • Continued progress in thrombosis research promises enhanced patient outcomes.